Together with the findings above, these data suggest the mechanisms underlying the role of ST6GAL1 in prostate cancer are multi-faceted, and also likely involve the regulation of immunosuppressive sialoglycans that can engage immune cells. Here, ST6GAL1 is linked to prostate cancer.